Titre :
  • Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel
Auteur : Durbecq, Virginie ; Paesmans, Marianne ; Cardoso, Fatima ; Desmedt, Christine ; Di Leo, Angelo ; Chan, Stephen ; Friedrichs, Kay ; Pinter, Tamas ; Van Belle, Simon ; Murray, Elizabeth ; Bodrogi, István ; Walpole, Euan ; Lesperance, Bernard ; Korec, Stefan ; Crown, John ; Simmonds, Peter ; Perren, Thimothy J. ; Leroy, Jean-Yves ; Rouas, Ghizlane ; Sotiriou, Christos ; Piccart-Gebhart, Martine ; Larsimont, Denis
Informations sur la publication : Molecular cancer therapeutics, 3, 10, (page 1207-1214)
Statut de publication : Publié, 2004-10
Sujet CREF : Cancérologie
Médecine pathologie humaine
Mots-clés MeSH : Adult
Aged
Antigens, Neoplasm
Breast Neoplasms -- drug therapy
Breast Neoplasms -- enzymology
Cell Line, Tumor
DNA Topoisomerases, Type II, Eukaryotic -- biosynthesis
DNA Topoisomerases, Type II, Eukaryotic -- genetics
DNA-Binding Proteins
Doxorubicin -- therapeutic use
Female
Humans
Immunohistochemistry
Middle Aged
Multivariate Analysis
Odds Ratio
Receptor, erbB-2 -- metabolism
Retrospective Studies
Taxoids -- therapeutic use
Treatment Outcome
Tumor Markers, Biological
Note : Clinical Trial
Clinical Trial, Phase III
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:1535-7163 
info:pii/3/10/1207
info:pmid/15486187
VX-005278